PEPTIDE MODIFIÉ, LIGAND DE RÉCEPEURS CB, TROUSSE, PROCÉDÉ IN VITRO POUR L'ÉVALUATION DE LA LIAISON AUX RÉCEPTEURS CB, UTILISATIONS ET COMPOSITION PHARMACEUTIQUE POUR MODULER L'ACTIVITÉ DE RÉCEPTEURS CB
The present invention discloses novel non-natural and modified peptides acting as cannabinoid (CB) receptors ligands, especially CB1 and/or CB2, useful as modulators of its activity； they are also described as a kit and a process in vitro for evaluating the binding to CB receptors, uses and pharmaceutical composition for modulating the CB receptors activity. The invention covers the non-natural peptide of SeqID:1 and those having at least 70% similarity related to the same, including as achievements specialty useful of the invention the non-natural peptides of SeqID:2, SeqID:3, SeqID:4, SeqID:5, SeqlD:6.
